Vaxcell Bio Therapeutics Co Stock Price To Earning
| 323990 Stock | KRW 12,810 390.00 2.95% |
Vaxcell Bio Therapeutics Co fundamentals help investors to digest information that contributes to Vaxcell Bio's financial success or failures. It also enables traders to predict the movement of Vaxcell Stock. The fundamental analysis module provides a way to measure Vaxcell Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxcell Bio stock.
Vaxcell |
Vaxcell Bio Therapeutics Co Company Price To Earning Analysis
Vaxcell Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Vaxcell Bio Therapeutics Co has a Price To Earning of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Earning (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Vaxcell Fundamentals
| Return On Equity | -21.18 | |||
| Current Valuation | 1.06 T | |||
| Shares Owned By Insiders | 13.55 % | |||
| Shares Owned By Institutions | 3.92 % | |||
| Gross Profit | (5.39 M) | |||
| EBITDA | (4.06 B) | |||
| Net Income | (4.76 B) | |||
| Cash And Equivalents | 27.31 B | |||
| Total Debt | 37.39 M | |||
| Cash Flow From Operations | (4.66 B) | |||
| Market Capitalization | 554.12 B | |||
| Total Asset | 31.28 B | |||
| Net Asset | 31.28 B |
About Vaxcell Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxcell Bio Therapeutics Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxcell Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxcell Bio Therapeutics Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vaxcell Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxcell Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcell Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Vaxcell Stock
Moving against Vaxcell Stock
The ability to find closely correlated positions to Vaxcell Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxcell Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxcell Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxcell Bio Therapeutics Co to buy it.
The correlation of Vaxcell Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxcell Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxcell Bio Therapeu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxcell Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vaxcell Stock
Vaxcell Bio financial ratios help investors to determine whether Vaxcell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vaxcell with respect to the benefits of owning Vaxcell Bio security.